Clinical Trial

Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of DW5421A/DW5421B Compared to Monotherapy of DW5421A

Completed Phase 3
View on ClinicalTrials.gov →
Summary
This is a multicenter, randomized, double-blind, active-controlled, parallel, phase III clinical trial to evaluate the efficacy and safety of combination therapy of DW5421A/DW5421B versus monotherapy of DW5421A in patients with primary hypercholesterolemia or mixed dyslipidemia.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-25.
Trial Details
NCT Number NCT07444762
Lead Sponsor Daewon Pharmaceutical Co., Ltd.
Conditions Primary Hypercholesterolemia, Mixed Dyslipidemia
Enrollment 184 participants
Start Date 2025-04-21
Primary Completion 2025-10-21 (estimated)
Study Completion 2025-10-21 (estimated)
Updated on ClinicalTrials.gov 2026-03-06